308 related articles for article (PubMed ID: 37210024)
1. Design of an international male contraceptive efficacy trial using a self-administered daily transdermal gel containing testosterone and segesterone acetate (Nestorone).
Amory JK; Blithe DL; Sitruk-Ware R; Swerdloff RS; Bremner WJ; Dart C; Liu PY; Thirumalai A; Nguyen BT; Anawalt BD; Lee MS; Page ST; Wang C
Contraception; 2023 Aug; 124():110064. PubMed ID: 37210024
[TBL] [Abstract][Full Text] [Related]
2. Acceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trial.
Roth MY; Shih G; Ilani N; Wang C; Page ST; Bremner WJ; Swerdloff RS; Sitruk-Ware R; Blithe DL; Amory JK
Contraception; 2014 Oct; 90(4):407-12. PubMed ID: 24981149
[TBL] [Abstract][Full Text] [Related]
3. Combined nestorone-testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men.
Anawalt BD; Roth MY; Ceponis J; Surampudi V; Amory JK; Swerdloff RS; Liu PY; Dart C; Bremner WJ; Sitruk-Ware R; Kumar N; Blithe DL; Page ST; Wang C
Andrology; 2019 Nov; 7(6):878-887. PubMed ID: 30969032
[TBL] [Abstract][Full Text] [Related]
4. A new combination of testosterone and nestorone transdermal gels for male hormonal contraception.
Ilani N; Roth MY; Amory JK; Swerdloff RS; Dart C; Page ST; Bremner WJ; Sitruk-Ware R; Kumar N; Blithe DL; Wang C
J Clin Endocrinol Metab; 2012 Oct; 97(10):3476-86. PubMed ID: 22791756
[TBL] [Abstract][Full Text] [Related]
5. Male contraception development: monitoring effective spermatogenesis suppression utilizing a user-controlled sperm concentration test compared with standard semen analysis.
Lue Y; Swerdloff R; Pak Y; Nguyen BT; Yuen F; Liu PY; Blithe DL; Wang C
Fertil Steril; 2023 Feb; 119(2):208-217. PubMed ID: 36347310
[TBL] [Abstract][Full Text] [Related]
6. Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men.
Mahabadi V; Amory JK; Swerdloff RS; Bremner WJ; Page ST; Sitruk-Ware R; Christensen PD; Kumar N; Tsong YY; Blithe D; Wang C
J Clin Endocrinol Metab; 2009 Jul; 94(7):2313-20. PubMed ID: 19366848
[TBL] [Abstract][Full Text] [Related]
7. Strategies to improve adherence and continuation of shorter-term hormonal methods of contraception.
Mack N; Crawford TJ; Guise JM; Chen M; Grey TW; Feldblum PJ; Stockton LL; Gallo MF
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD004317. PubMed ID: 31013349
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.
Guerin JF; Rollet J
Int J Androl; 1988 Jun; 11(3):187-99. PubMed ID: 2970439
[TBL] [Abstract][Full Text] [Related]
9. Development of new hormonal male contraception for the couple.
Kroopnick JM; Lee MS; Blithe DL
Andrology; 2024 May; ():. PubMed ID: 38745531
[TBL] [Abstract][Full Text] [Related]
10. Characteristics associated with suppression of spermatogenesis in a male hormonal contraceptive trial using testosterone and Nestorone(®) gels.
Roth MY; Ilani N; Wang C; Page ST; Bremner WJ; Swerdloff RS; Dart C; Sitruk-Ware R; Kumar N; Blithe D; Amory JK
Andrology; 2013 Nov; 1(6):899-905. PubMed ID: 24123845
[TBL] [Abstract][Full Text] [Related]
11. Impact of various progestins with or without transdermal testosterone on gonadotropin levels for non-invasive hormonal male contraception: a randomized clinical trial.
Zitzmann M; Rohayem J; Raidt J; Kliesch S; Kumar N; Sitruk-Ware R; Nieschlag E
Andrology; 2017 May; 5(3):516-526. PubMed ID: 28189123
[TBL] [Abstract][Full Text] [Related]
12. Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist.
Page ST; Amory JK; Anawalt BD; Irwig MS; Brockenbrough AT; Matsumoto AM; Bremner WJ
J Clin Endocrinol Metab; 2006 Nov; 91(11):4374-80. PubMed ID: 16940442
[TBL] [Abstract][Full Text] [Related]
13. Male hormonal contraceptives: current status and future prospects.
Amory JK
Treat Endocrinol; 2005; 4(6):333-41. PubMed ID: 16318399
[TBL] [Abstract][Full Text] [Related]
14. Hormonal male contraception: progress and prospects for the 21st century.
Handelsman DJ
Aust N Z J Med; 1995 Dec; 25(6):808-16. PubMed ID: 8770357
[TBL] [Abstract][Full Text] [Related]
15. Canadian Contraception Consensus (Part 1 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
[TBL] [Abstract][Full Text] [Related]
16. Male contraception: narrative review of ongoing research.
Louwagie EJ; Quinn GFL; Pond KL; Hansen KA
Basic Clin Androl; 2023 Nov; 33(1):30. PubMed ID: 37940863
[TBL] [Abstract][Full Text] [Related]
17. Canadian Contraception Consensus (Part 2 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
[TBL] [Abstract][Full Text] [Related]
18. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
[TBL] [Abstract][Full Text] [Related]
19. Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men.
Gu Y; Liang X; Wu W; Liu M; Song S; Cheng L; Bo L; Xiong C; Wang X; Liu X; Peng L; Yao K
J Clin Endocrinol Metab; 2009 Jun; 94(6):1910-5. PubMed ID: 19293262
[TBL] [Abstract][Full Text] [Related]
20. Progress and prospects in male hormonal contraception.
Amory JK
Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):255-60. PubMed ID: 18438174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
